Clinical Trials Browser

Esophageal Squamous Cell Carcinoma × spartalizumab × 90 days × Clear all

NCT07403136 2026-05-11

Vebrekotuzumab ± Anti-PD-1 in Pretreated Advanced ESCC

Phase 2 Recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma